Item 1.01		Entry into a Material Definitive Agreement.

     On January 12, 2007, the Board of Directors of Adeza Biomedical Corporation (the “Company”) approved certain amendments to the Company’s management continuity agreements (each, an “Agreement” and collectively, the “Agreements”) with each of the Company’s Chief Executive Officer; Chief Financial Officer; and other named executive officers. The Company believes that the amended Agreements are appropriate for the Company’s needs and consistent with industry standards.

     The amendments to the Agreement with the Company’s Chief Executive Officer provide, among other things, that in the event that the Chief Executive Officer’s employment is terminated other than for “cause” or if he resigns for “good reason” (each as defined in the Agreement) at any time within 12 months following a “change of control” (as defined in the Agreement), the Chief Executive Officer will receive severance benefits equal to 24 months of his salary, a lump sum payment equal to 200% of the bonus payment made to the Chief Executive Officer for the prior fiscal year, a lump sum payment equal to a prorated portion of the bonus payment made to the Chief Executive Officer for the prior fiscal year based on the number of completed months of employment in the year in which the termination occurs and continuation of his health insurance benefits at the Company’s expense under COBRA for up to 24 months.

     The amendments to the Agreements with the Company’s Chief Financial Officer and the Company’s other named executive officers provide, among other things, that in the event that such officer’s employment is terminated other than for “cause” or if he/she resigns for “good reason” (each as defined in the Agreement) at any time within 12 months following a “change of control” (as defined in the Agreement), such officer will receive severance benefits equal to 18 months of his/her salary, a lump sum payment equal to 150% of the bonus payment made to such officer for the prior fiscal year, a lump sum payment equal to a prorated portion of the bonus payment made to such officer for the prior fiscal year based on the number of completed months of employment in the year in which the termination occurs, and continuation of his/her health insurance benefits at the Company’s expense under COBRA for up to 18 months.

     Additional terms and conditions are set forth in the Agreements. The foregoing descriptions are subject to, and qualified in their entirety by, the Agreements.

Item 5.02.		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

     The following sets forth a summary of the bonuses awarded for performance in 2006 for the Company’s (i) Chief Executive Officer; (ii) Chief Financial Officer; and (iii) other named executive officers for whom compensation disclosure was required in the Company’s most recent proxy statement filed with the Securities and Exchange Commission, which bonuses were approved by the Board of Directors of the Company on January 12, 2007.